Typically, and in this case, the "vector" is the delivery package used to deliver a particular gene sequence to the targeted site.
When you say a company has >100 vectors, I assume you mean they used one (or maybe two) vector to package any one of a hundred different gene sequences, not that they have >100 different ways to deliver a particular gene sequence into a cell or organ.
If their approach to gene delivery doesn't work well, or isn't protected by patents, it isn't worth much.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.